Thyrocare Technologies Limited (BOM: 539871)

Market Cap	45.42B
Revenue (ttm)	5.94B
Net Income (ttm)	776.30M
Shares Out	52.95M
EPS (ttm)	14.68
PE Ratio	58.45
Forward PE	43.38
Dividend	18.00 (2.11%)
Ex-Dividend Date	Aug 16, 2024

Volume	1,621
Open	859.65
Previous Close	854.85
Day's Range	851.75 - 865.45
52-Week Range	511.00 - 930.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2024

About Thyrocare Technologies

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests adm...

• Industry: Medical Laboratories
• Founded: 1996
• Employees: 1,693
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539871

Financial Performance

In 2023, Thyrocare Technologies's revenue was 5.72 billion, an increase of 8.58% compared to the previous year's 5.27 billion. Earnings were 707.60 million, an increase of 9.72%.